Azione AVTX AVALO THERAPEUTICS, INC.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Avalo Therapeutics, Inc.

Azioni

AVTX

US05338F3064

Mercato chiuso - Nasdaq
Altri mercati azionari
 22:30:00 08/07/2024 		Variaz. 5gg Var. 1 gen.
13,15 USD +4,45% Grafico intraday di Avalo Therapeutics, Inc. +4,28% +44,51%
24/06 Avalo Therapeutics nomina il direttore legale MT
24/06 Avalo Therapeutics, Inc. nomina Paul Varki come Responsabile Legale CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Avalo Therapeutics : 2024 Proxy Statement
Avalo Therapeutics Names Chief Legal Officer
Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
Avalo Therapeutics, Inc. Appoints Paul Varki as Chief Legal Officer
Avalo Therapeutics : June 2024 Corporate Presentation
Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit
Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
North American Morning Briefing : Stock Futures -2-
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
Avalo Reports 2023 Financial Results and Provides Business Updates
Avalo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Avalo Reports 2023 Financial Results and Provides Business Updates
Sector Update: Health Care Stocks Rise Late Afternoon
Top Midday Gainers
Wall Street Set to Open Flat in Thursday Trading; Q4 US GDP Revised Up, Weekly Jobless Claims Fall
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Key Economic Data
US Futures Little Changed Pre-Bell Thursday Ahead of Raft of Economic Data
Top Premarket Gainers
Avalo Therapeutics, Inc. announced that it has received $115.6 million in funding from Deep Track Capital, LP, TCG Crossover Management, LLC, BVF Partners L.P., RA Capital Management, L.P., Commodore Capital LP, Petrichor Holdings, LLC
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione AVTX
  4. Notizie Avalo Therapeutics, Inc.
  5. Altre lingue